Clinical Trial Update: The Effect of Therapy With Bevacizumab in Chronic Central Serous Chorioretinopathy [NA]

View source ↗

Summary

This clinical trial update reports on the use of bevacizumab for chronic central serous chorioretinopathy, but does not provide results in the available snippet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Chorioretinopathy

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Hallym University Medical Center | Conditions: Central Serous Chorioretinopathy | NA | Status: UNKNOWN